Discover how a 13-year-old boy with Glycogen Storage Disorder Type 1A manages his rare condition by drinking cornstarch water ...
GlobalData on MSN
Acesion begins patient enrolment in AP31969 Phase II AF study
The trial’s primary efficacy endpoint is AF burden, which refers to the percentage of time a participant is in AF.
The press release issued by Tuktu Resources Ltd. (TSXV: TUK) (“Tuktu” or the “Company”) dated January 7, 2026 (the “Press ...
Acesion Pharma has begun enrolling patients into a phase 2 clinical trial of AP31969, its novel oral SK ion channel inhibitor being developed for rhythm control in atrial fibrillation.
AP31969 is a novel, first-in-class, oral SK ion channel inhibitor intended for rhythm control of atrial fibrillation and has recently completed Phase 1 in healthy volunteersPhase 2 trial will assess ...
Discover how the economy impacts employability and explore essential skills that enhance job prospects, from technical to ...
PRIME Marine has released a set of feature enhancements to its Vessel Management System, introducing CMS-aligned ...
Auditor Appointment Rules Explained Under Section 139 of Companies Act; How Auditors Are Appointed, Reappointed, and Rotated in Companies; Section 139 Decoded ...
China’s Wangu field in Hunan logs 40 veins near 2,000 m; models reach 3,000 m, with 300 already indicated and a valuation ...
Malawi breaking news publishing 24 hours a day news about Malawi, Malawi Business, Malawi Tourism, Malawi Politics, Malawi News ...
Business development companies are set for their worst year relative to the SandP 500 since 2020, leading some investors to question their future in the $1.7 trillion private credit market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback